Yingwei Qi

903 total citations
23 papers, 681 citations indexed

About

Yingwei Qi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yingwei Qi has authored 23 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Yingwei Qi's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Yingwei Qi is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Yingwei Qi collaborates with scholars based in United States, China and Australia. Yingwei Qi's co-authors include Sumithra J. Mandrekar, Charles Erlichman, Alex A. Adjei, Catherine S. Bradley, Ingrid Nygaard, M. Bridget Zimmerman, Steven E. Schild, Julian R. Molina, Aminah Jatoi and James E. Krook and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

In The Last Decade

Yingwei Qi

23 papers receiving 668 citations

Peers

Yingwei Qi

ONCOL

PRM

SURGE

EPIDE

Toshiyuki Sumi Japan

Guilherme Cantuaria United States

Grenville Oades United Kingdom

Xiuyi Zhi China

Chiao‐En Wu Taiwan

Erik A. Wist Norway

Ayman Elnemr Japan

Kunihiko Yoshioka Japan

S. J. Harland United Kingdom

B D Evans New Zealand

Toshiyuki Sumi Japan

Yingwei Qi

200 ×0.6

ONCOL

262 ×1.2

88 ×0.5

PRM

157 ×1.1

SURGE

91 ×0.8

EPIDE

Citations per year, relative to Yingwei Qi Yingwei Qi (= 1×) peers Toshiyuki Sumi

Countries citing papers authored by Yingwei Qi

Since Specialization

Citations

This map shows the geographic impact of Yingwei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingwei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingwei Qi more than expected).

Fields of papers citing papers by Yingwei Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingwei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingwei Qi. The network helps show where Yingwei Qi may publish in the future.

Co-authorship network of co-authors of Yingwei Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Yingwei Qi. A scholar is included among the top collaborators of Yingwei Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingwei Qi. Yingwei Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molina, Julian R., Grace K. Dy, Gary A. Croghan, et al.. (2020). A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors. Investigational New Drugs. 38(6). 1755–1762. 11 indexed citations

Dy, Grace K., Julian R. Molina, Yingwei Qi, et al.. (2014). NCCTG N0821 (Alliance): A Phase II First-Line Study of Pemetrexed, Carboplatin, and Bevacizumab in Elderly Patients with Advanced Nonsquamous Non–Small-Cell Lung Cancer With Good Performance Status. Journal of Thoracic Oncology. 9(8). 1146–1153. 6 indexed citations

Costello, Brian A., Mitesh J. Borad, Yingwei Qi, et al.. (2014). Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors. Investigational New Drugs. 32(4). 710–716. 38 indexed citations

Mansfield, Aaron S., Alan P. Fields, Aminah Jatoi, et al.. (2013). Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. Anti-Cancer Drugs. 24(10). 1079–1083. 43 indexed citations

Chen, Jun, Yingwei Qi, Jason A. Wampfler, et al.. (2012). Effect of cigarette smoking on quality of life in small cell lung cancer patients. European Journal of Cancer. 48(11). 1593–1601. 58 indexed citations

Qi, Yingwei, Katie L. Allen Ziegler, Shauna L. Hillman, et al.. (2012). Impact of disease progression date determination on progression‐free survival estimates in advanced lung cancer. Cancer. 118(21). 5358–5365. 14 indexed citations

Costello, Brian A., Yingwei Qi, Mitesh J. Borad, et al.. (2012). Phase I trial of everolimus, gemcitabine and cisplatin for patients with solid tumors refractory to standard therapy.. Journal of Clinical Oncology. 30(15_suppl). e13052–e13052. 1 indexed citations

Mandrekar, Sumithra J., Nathan R. Foster, Yingwei Qi, et al.. (2012). Impact of disease progression (DP) date determination method on post progression survival (PPS) and DP metrics in advanced lung cancer.. Journal of Clinical Oncology. 30(15_suppl). 7605–7605. 1 indexed citations

Dy, Grace K., Julian R. Molina, Yingwei Qi, et al.. (2012). N0821: A phase II first-line study of a combination of pemetrexed (P), carboplatin (C), and bevacizumab (B) in elderly patients with good performance status (PS < 2).. Journal of Clinical Oncology. 30(15_suppl). 7555–7555. 3 indexed citations

10.

Jatoi, Aminah, et al.. (2011). The Purported Effects of Alcohol on Appetite and Weight in Lung Cancer Patients. Nutrition and Cancer. 63(8). 1251–1255. 2 indexed citations

11.

Bryce, Alan H., Jann N. Sarkaria, Joel M. Reid, et al.. (2011). Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors. Investigational New Drugs. 30(5). 1934–1941. 22 indexed citations

12.

Baggstrom, Maria Q., Yingwei Qi, Marianna Koczywas, et al.. (2011). A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer. Journal of Thoracic Oncology. 6(10). 1757–1760. 133 indexed citations

13.

Mandrekar, Sumithra J., Yingwei Qi, Shauna L. Hillman, et al.. (2010). Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(1). 3–9. 32 indexed citations

14.

Foster, Nathan R., Yingwei Qi, Qian Shi, et al.. (2010). Tumor response and progression‐free survival as potential surrogate endpoints for overall survival in extensive stage small‐cell lung cancer. Cancer. 117(6). 1262–1271. 93 indexed citations

15.

Li, Yan, Michael J. Krowka, Yingwei Qi, et al.. (2010). Alpha1-Antitrypsin Deficiency Carriers, Serum Alpha 1-Antitrypsin Concentration, and Non-small Cell Lung Cancer Survival. Journal of Thoracic Oncology. 6(2). 291–295. 19 indexed citations

16.

Baggstrom, Maria Q., Ramaswamy Govindan, Athanassios Argiris, et al.. (2010). Phase II trial of R-(-)-gossypol acetic acid (NSC 726190, AT-101) in patients with recurrent extensive stage small cell lung cancer (ES-SCLC).. Journal of Clinical Oncology. 28(15_suppl). e17523–e17523. 3 indexed citations

17.

Jatoi, Aminah, Yingwei Qi, Ruoxiang Jiang, et al.. (2009). The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Supportive Care in Cancer. 18(10). 1299–1304. 14 indexed citations

18.

Qi, Yingwei, Steven E. Schild, Sumithra J. Mandrekar, et al.. (2009). Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(9). 1075–1082. 52 indexed citations

19.

Schild, Steven E., Yingwei Qi, Alex A. Adjei, et al.. (2008). Baseline quality of life (QOL) as a prognostic factor for overall survival (OS) in patients (Pts) with advanced stage non-small cell lung cancer (A-NSCLC): An analysis of NCCTG studies. Journal of Clinical Oncology. 26(15_suppl). 8076–8076. 4 indexed citations

20.

Bradley, Catherine S., M. Bridget Zimmerman, Yingwei Qi, & Ingrid Nygaard. (2007). Natural History of Pelvic Organ Prolapse in Postmenopausal Women. Obstetrics and Gynecology. 109(4). 848–854. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact